A population-based record linkage study of mortality in hepatitis C-diagnosed persons with or without HIV coinfection in Scotland

Scott A. McDonald, Sharon J. Hutchinson, Sheila M. Bird, Peter R. Mills, John Dillon, Mick Bloor, Chris Robertson, Martin Donaghy, Peter Hayes, Lesley Graham

    Research output: Contribution to journalArticle

    41 Citations (Scopus)

    Abstract

    Infection with the hepatitis C virus (HCV) is known to increase the risk of death from severe liver disease and, because HCV status is strongly associated with a history of injecting drug use, the effect of a key disease progression cofactor, infection with human immunodeficiency virus (HIV), is of interest. We examined all-cause, liver-related and drug-related mortality and excess risk of death from these causes in a large cohort of HCV-monoinfected and HIV-coinfected persons in Scotland. The study population consisted of 20,163 persons confirmed to be infected with hepatitis C through laboratory testing in Scotland between 1991 and 2005. Records with sufficient identifiers were linked to the General Register Office for Scotland death register to retrieve associated mortality data, and were further linked to a national database of HIV-positive individuals to determine coinfection status. A total of 1715 HCV monoinfected and 305 HIV coinfected persons died of any cause during the follow-up period (mean of 5.4 and 6.4 years, respectively). Significant excess mortality was observed in both HCV monoinfected and HIV coinfected populations from liver-related underlying causes (standardised mortality ratios of 25, 95% CI=23-27; and 37, 95% CI =26-52 for the two groups, respectively) and drug-related causes (25, 95% CI=23-27; 39, 95% CI=28-53. The risk of death from hepatocellular carcinoma, alcoholic or non-alcoholic liver disease, or from a drug-related cause, was greatly increased compared with the general Scottish population, with the highest standardised mortality ratio observed for hepatocellular carcinoma in the monoinfected group (70, 95% CI=57-85). This study has revealed considerable excess mortality from liver-and drug-related causes in the Scottish HCV-diagnosed population; these data are crucial to inform on the clinical management, and projected future public health burden, of HCV infection.

    Original languageEnglish
    Pages (from-to)271-283
    Number of pages13
    JournalStatistical Methods in Medical Research
    Volume18
    Issue number3
    DOIs
    Publication statusPublished - Jun 2009

    Keywords

    • IMMUNODEFICIENCY-VIRUS INFECTION
    • DRUG-USERS
    • COHORT
    • DEATH
    • CIRRHOSIS
    • RATES

    Cite this

    McDonald, Scott A. ; Hutchinson, Sharon J. ; Bird, Sheila M. ; Mills, Peter R. ; Dillon, John ; Bloor, Mick ; Robertson, Chris ; Donaghy, Martin ; Hayes, Peter ; Graham, Lesley. / A population-based record linkage study of mortality in hepatitis C-diagnosed persons with or without HIV coinfection in Scotland. In: Statistical Methods in Medical Research. 2009 ; Vol. 18, No. 3. pp. 271-283.
    @article{730d8fa03520468d98c2b528ea3a0e3d,
    title = "A population-based record linkage study of mortality in hepatitis C-diagnosed persons with or without HIV coinfection in Scotland",
    abstract = "Infection with the hepatitis C virus (HCV) is known to increase the risk of death from severe liver disease and, because HCV status is strongly associated with a history of injecting drug use, the effect of a key disease progression cofactor, infection with human immunodeficiency virus (HIV), is of interest. We examined all-cause, liver-related and drug-related mortality and excess risk of death from these causes in a large cohort of HCV-monoinfected and HIV-coinfected persons in Scotland. The study population consisted of 20,163 persons confirmed to be infected with hepatitis C through laboratory testing in Scotland between 1991 and 2005. Records with sufficient identifiers were linked to the General Register Office for Scotland death register to retrieve associated mortality data, and were further linked to a national database of HIV-positive individuals to determine coinfection status. A total of 1715 HCV monoinfected and 305 HIV coinfected persons died of any cause during the follow-up period (mean of 5.4 and 6.4 years, respectively). Significant excess mortality was observed in both HCV monoinfected and HIV coinfected populations from liver-related underlying causes (standardised mortality ratios of 25, 95{\%} CI=23-27; and 37, 95{\%} CI =26-52 for the two groups, respectively) and drug-related causes (25, 95{\%} CI=23-27; 39, 95{\%} CI=28-53. The risk of death from hepatocellular carcinoma, alcoholic or non-alcoholic liver disease, or from a drug-related cause, was greatly increased compared with the general Scottish population, with the highest standardised mortality ratio observed for hepatocellular carcinoma in the monoinfected group (70, 95{\%} CI=57-85). This study has revealed considerable excess mortality from liver-and drug-related causes in the Scottish HCV-diagnosed population; these data are crucial to inform on the clinical management, and projected future public health burden, of HCV infection.",
    keywords = "IMMUNODEFICIENCY-VIRUS INFECTION, DRUG-USERS, COHORT, DEATH, CIRRHOSIS, RATES",
    author = "McDonald, {Scott A.} and Hutchinson, {Sharon J.} and Bird, {Sheila M.} and Mills, {Peter R.} and John Dillon and Mick Bloor and Chris Robertson and Martin Donaghy and Peter Hayes and Lesley Graham",
    year = "2009",
    month = "6",
    doi = "10.1177/0962280208094690",
    language = "English",
    volume = "18",
    pages = "271--283",
    journal = "Statistical Methods in Medical Research",
    issn = "0962-2802",
    publisher = "SAGE Publications",
    number = "3",

    }

    McDonald, SA, Hutchinson, SJ, Bird, SM, Mills, PR, Dillon, J, Bloor, M, Robertson, C, Donaghy, M, Hayes, P & Graham, L 2009, 'A population-based record linkage study of mortality in hepatitis C-diagnosed persons with or without HIV coinfection in Scotland', Statistical Methods in Medical Research, vol. 18, no. 3, pp. 271-283. https://doi.org/10.1177/0962280208094690

    A population-based record linkage study of mortality in hepatitis C-diagnosed persons with or without HIV coinfection in Scotland. / McDonald, Scott A.; Hutchinson, Sharon J.; Bird, Sheila M.; Mills, Peter R.; Dillon, John; Bloor, Mick; Robertson, Chris; Donaghy, Martin; Hayes, Peter; Graham, Lesley.

    In: Statistical Methods in Medical Research, Vol. 18, No. 3, 06.2009, p. 271-283.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - A population-based record linkage study of mortality in hepatitis C-diagnosed persons with or without HIV coinfection in Scotland

    AU - McDonald, Scott A.

    AU - Hutchinson, Sharon J.

    AU - Bird, Sheila M.

    AU - Mills, Peter R.

    AU - Dillon, John

    AU - Bloor, Mick

    AU - Robertson, Chris

    AU - Donaghy, Martin

    AU - Hayes, Peter

    AU - Graham, Lesley

    PY - 2009/6

    Y1 - 2009/6

    N2 - Infection with the hepatitis C virus (HCV) is known to increase the risk of death from severe liver disease and, because HCV status is strongly associated with a history of injecting drug use, the effect of a key disease progression cofactor, infection with human immunodeficiency virus (HIV), is of interest. We examined all-cause, liver-related and drug-related mortality and excess risk of death from these causes in a large cohort of HCV-monoinfected and HIV-coinfected persons in Scotland. The study population consisted of 20,163 persons confirmed to be infected with hepatitis C through laboratory testing in Scotland between 1991 and 2005. Records with sufficient identifiers were linked to the General Register Office for Scotland death register to retrieve associated mortality data, and were further linked to a national database of HIV-positive individuals to determine coinfection status. A total of 1715 HCV monoinfected and 305 HIV coinfected persons died of any cause during the follow-up period (mean of 5.4 and 6.4 years, respectively). Significant excess mortality was observed in both HCV monoinfected and HIV coinfected populations from liver-related underlying causes (standardised mortality ratios of 25, 95% CI=23-27; and 37, 95% CI =26-52 for the two groups, respectively) and drug-related causes (25, 95% CI=23-27; 39, 95% CI=28-53. The risk of death from hepatocellular carcinoma, alcoholic or non-alcoholic liver disease, or from a drug-related cause, was greatly increased compared with the general Scottish population, with the highest standardised mortality ratio observed for hepatocellular carcinoma in the monoinfected group (70, 95% CI=57-85). This study has revealed considerable excess mortality from liver-and drug-related causes in the Scottish HCV-diagnosed population; these data are crucial to inform on the clinical management, and projected future public health burden, of HCV infection.

    AB - Infection with the hepatitis C virus (HCV) is known to increase the risk of death from severe liver disease and, because HCV status is strongly associated with a history of injecting drug use, the effect of a key disease progression cofactor, infection with human immunodeficiency virus (HIV), is of interest. We examined all-cause, liver-related and drug-related mortality and excess risk of death from these causes in a large cohort of HCV-monoinfected and HIV-coinfected persons in Scotland. The study population consisted of 20,163 persons confirmed to be infected with hepatitis C through laboratory testing in Scotland between 1991 and 2005. Records with sufficient identifiers were linked to the General Register Office for Scotland death register to retrieve associated mortality data, and were further linked to a national database of HIV-positive individuals to determine coinfection status. A total of 1715 HCV monoinfected and 305 HIV coinfected persons died of any cause during the follow-up period (mean of 5.4 and 6.4 years, respectively). Significant excess mortality was observed in both HCV monoinfected and HIV coinfected populations from liver-related underlying causes (standardised mortality ratios of 25, 95% CI=23-27; and 37, 95% CI =26-52 for the two groups, respectively) and drug-related causes (25, 95% CI=23-27; 39, 95% CI=28-53. The risk of death from hepatocellular carcinoma, alcoholic or non-alcoholic liver disease, or from a drug-related cause, was greatly increased compared with the general Scottish population, with the highest standardised mortality ratio observed for hepatocellular carcinoma in the monoinfected group (70, 95% CI=57-85). This study has revealed considerable excess mortality from liver-and drug-related causes in the Scottish HCV-diagnosed population; these data are crucial to inform on the clinical management, and projected future public health burden, of HCV infection.

    KW - IMMUNODEFICIENCY-VIRUS INFECTION

    KW - DRUG-USERS

    KW - COHORT

    KW - DEATH

    KW - CIRRHOSIS

    KW - RATES

    U2 - 10.1177/0962280208094690

    DO - 10.1177/0962280208094690

    M3 - Article

    C2 - 19036907

    VL - 18

    SP - 271

    EP - 283

    JO - Statistical Methods in Medical Research

    JF - Statistical Methods in Medical Research

    SN - 0962-2802

    IS - 3

    ER -